Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells

Abstract Tumor relapse in triple negative breast cancer patients has been implicated to chemoresistant cancer stem cells (CSCs), which under favorable conditions culminate in tumor re-formation and metastasis. Hence, eradication of CSCs during systemic chemotherapy is imperative. CSCs were sorted us...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pritha Mukherjee, Arnab Gupta, Dhrubajyoti Chattopadhyay, Urmi Chatterji
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/50cc4ab0478c48508109340cb314607b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!